Karah Parschauer
2017
In 2017, Karah Parschauer earned a total compensation of $1.4M as General Counsel and Executive Vice President at Ultragenyx Pharmaceutical, a 47% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $150,070 |
|---|---|
| Option Awards | $660,805 |
| Salary | $357,310 |
| Stock Awards | $246,443 |
| Other | $19,680 |
| Total | $1,434,308 |
Parschauer received $660.8K in option awards, accounting for 46% of the total pay in 2017.
Parschauer also received $150.1K in non-equity incentive plan, $357.3K in salary, $246.4K in stock awards and $19.7K in other compensation.
Rankings
In 2017, Karah Parschauer's compensation ranked 7,221st out of 14,666 executives tracked by ExecPay. In other words, Parschauer earned more than 50.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,221 out of 14,666 | 51st |
Division Manufacturing | 2,684 out of 5,768 | 54th |
Major group Chemicals And Allied Products | 877 out of 2,074 | 58th |
Industry group Drugs | 685 out of 1,730 | 60th |
Industry Pharmaceutical Preparations | 538 out of 1,329 | 60th |
Source: SEC filing on April 22, 2019.
Parschauer's colleagues
We found five more compensation records of executives who worked with Karah Parschauer at Ultragenyx Pharmaceutical in 2017.
2017
Emil Kakkis
Ultragenyx Pharmaceutical
Chief Executive Officer
2017
Jayson Dallas
Ultragenyx Pharmaceutical
Chief Commercial Officer and Executive Vice President
2017
Shalini Sharp
Ultragenyx Pharmaceutical
Chief Financial Officer
2017
Thomas Kassberg
Ultragenyx Pharmaceutical
Chief Business Officers and Executive Vice President
2017
John Pinion
Ultragenyx Pharmaceutical